Li H - Search Results

1

Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy.

Lou M, Liu Q, Ren G, Zeng J, Xiang X, Ding Y, Lin Q, Zhong T, Liu X, Zhu L, Qi H, Shen J, Li H, Shao J. Lou M, et al. Among authors: li h. J Biol Chem. 2017 Jun 2;292(22):9136-9149. doi: 10.1074/jbc.M117.783365. Epub 2017 Apr 14. J Biol Chem. 2017. PMID: 28411237 Free PMC article.

2

Integrative Analysis Reveals Across-Cancer Expression Patterns and Clinical Relevance of Ribonucleotide Reductase in Human Cancers.

Ding Y, Zhong T, Wang M, Xiang X, Ren G, Jia Z, Lin Q, Liu Q, Dong J, Li L, Li X, Jiang H, Zhu L, Li H, Shen D, Teng L, Li C, Shao J. Ding Y, et al. Among authors: li c, li x, li h, li l. Front Oncol. 2019 Oct 4;9:956. doi: 10.3389/fonc.2019.00956. eCollection 2019. Front Oncol. 2019. PMID: 31637211 Free PMC article.

3

FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer.

Li H, Qi Z, Niu Y, Yang Y, Li M, Pang Y, Liu M, Cheng X, Xu M, Wang Z. Li H, et al. Among authors: li m. Oncogene. 2021 Oct;40(40):5938-5949. doi: 10.1038/s41388-021-01957-5. Epub 2021 Aug 6. Oncogene. 2021. PMID: 34363022 Free PMC article.

4

Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.

Zhou H, Chen L, Lei Y, Li T, Li H, Cheng X. Zhou H, et al. Among authors: li t, li h. Curr Probl Cancer. 2021 Apr;45(2):100660. doi: 10.1016/j.currproblcancer.2020.100660. Epub 2020 Sep 29. Curr Probl Cancer. 2021. PMID: 33012523

5

Fructose‑1,6‑bisphosphatase‑1 decrease may promote carcinogenesis and chemoresistance in cervical cancer.

Li H, Li M, Pang Y, Liu F, Sheng D, Cheng X. Li H, et al. Among authors: li m. Mol Med Rep. 2017 Dec;16(6):8563-8571. doi: 10.3892/mmr.2017.7665. Epub 2017 Sep 29. Mol Med Rep. 2017. PMID: 28990097

6

Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.

Chen L, Cheng X, Tu W, Qi Z, Li H, Liu F, Yang Y, Zhang Z, Wang Z. Chen L, et al. Among authors: li h. Cell Oncol (Dordr). 2019 Oct;42(5):679-690. doi: 10.1007/s13402-019-00455-x. Epub 2019 Jul 20. Cell Oncol (Dordr). 2019. PMID: 31325096

7

Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer.

Yang Y, Xia L, Wu Y, Zhou H, Chen X, Li H, Xu M, Qi Z, Wang Z, Sun H, Cheng X. Yang Y, et al. Among authors: li h. Cancer Commun (Lond). 2021 Jun;41(6):511-527. doi: 10.1002/cac2.12157. Epub 2021 May 3. Cancer Commun (Lond). 2021. PMID: 33939321 Free PMC article.

8

Decreased secretoglobin family 2A member 1expression is associated with poor outcomes in endometrial cancer.

Zhou H, Zou X, Li H, Li T, Chen L, Cheng X. Zhou H, et al. Among authors: li t, li h. Oncol Lett. 2020 Oct;20(4):24. doi: 10.3892/ol.2020.11885. Epub 2020 Jul 16. Oncol Lett. 2020. PMID: 32774497 Free PMC article.

9

Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer.

Li H, Tong X, Xu Y, Wang M, Dai H, Shi T, Sun M, Chen K, Cheng X, Wei Q. Li H, et al. Carcinogenesis. 2019 Oct 16;40(10):1209-1219. doi: 10.1093/carcin/bgz092. Carcinogenesis. 2019. PMID: 31083717

10

How to evaluate the adequacy of staging for nodal-negative epithelial ovarian cancer? Use of nodal staging score.

Xu Y, Li H, Tong X, Pang Y, Tong X, Li L, Cheng L. Xu Y, et al. Among authors: li h, li l. J Gynecol Oncol. 2019 Mar;30(2):e21. doi: 10.3802/jgo.2019.30.e21. Epub 2018 Dec 4. J Gynecol Oncol. 2019. PMID: 30740953 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122,404 results

Search Page

Filters